Claims
- 1. A compound of formula ##STR4## in which R is hydrogen or C.sub.1 -C.sub.6 alkyl group; provided however, that when R is hydrogen the C-atoms marked by (a) and (b) have (R,R) or (S,R) configuration, and the salts thereof, when R is hydrogen, with pharmaceutically acceptable bases.
- 2. A compound according to claim 1 above, which is N-acetyl-S[(2S)-2-(4-isobutylphenyl)-propionyl]-(R)-cysteine.
- 3. A compound according to claim 1 above, which is N-acetyl-S[(2R)-2-(4-isobutylphenyl)-propionyl]-(R)-cysteine.
- 4. A pharmaceutical composition for the treatment of ischemia and reperfusion syndromes consisting essentially of an effective amount of a compound of the formula: ##STR5## in which R is hydrogen or a C.sub.1 -C.sub.6 alkyl group, or a salt thereof, when R is H, with a pharmaceutically acceptable base, together with a pharmaceutically acceptable carrier.
Priority Claims (1)
Number |
Date |
Country |
Kind |
21111A/86 |
Jul 1986 |
ITX |
|
Parent Case Info
This is a division of application Ser. No. 072,714 filed July 13, 1987.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4515807 |
Debourge et al. |
May 1985 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
72714 |
Jul 1987 |
|